Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $719.28 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $258.60 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $227.00 | 2 | $0 (2021) |
| Boston Scientific Corporation | $166.36 | 1 | $0 (2022) |
| Allergan, Inc. | $50.87 | 3 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $16.45 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $139.72 | 2 | ABBVIE INC. ($139.72) |
| 2023 | $21.69 | 1 | ABBVIE INC. ($21.69) |
| 2022 | $298.60 | 6 | Boston Scientific Corporation ($166.36) |
| 2021 | $141.55 | 3 | AstraZeneca Pharmaceuticals LP ($109.28) |
| 2019 | $117.72 | 1 | AstraZeneca Pharmaceuticals LP ($117.72) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $122.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/04/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $166.36 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/19/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/06/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $70.89 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/18/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/15/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $109.28 | General |
| Category: Respiratory | ||||||
| 04/27/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: PSYCHIATRY | ||||||
| 05/02/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $117.72 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 456 | 1,366 | $174,239 | $118,573 |
| 2022 | 12 | 392 | 1,155 | $139,010 | $99,339 |
| 2021 | 9 | 233 | 909 | $104,334 | $76,836 |
| 2020 | 6 | 144 | 557 | $55,020 | $43,003 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 303 | $47,536 | $32,739 | 68.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 285 | $31,712 | $21,511 | 67.8% |
| 98928 | Osteopathic manipulative treatment, 7-8 body regions | Office | 2023 | 59 | 272 | $23,633 | $16,352 | 69.2% |
| 98929 | Osteopathic manipulative treatment, 9-10 body regions | Office | 2023 | 50 | 193 | $19,688 | $13,439 | 68.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 20 | 45 | $10,014 | $7,002 | 69.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $11,664 | $6,955 | 59.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 11 | 17 | $9,482 | $6,626 | 69.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 20 | 43 | $4,888 | $3,407 | 69.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 11 | 15 | $4,613 | $3,223 | 69.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 11 | 29 | $3,680 | $2,374 | 64.5% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 12 | 20 | $1,887 | $1,286 | 68.1% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 14 | 23 | $1,675 | $1,167 | 69.7% |
| 76882 | Limited ultrasound scan of joint or other extremity structure except blood vessels | Office | 2023 | 22 | 32 | $1,657 | $1,163 | 70.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 19 | $1,348 | $833.51 | 61.9% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 15 | 15 | $762.15 | $497.28 | 65.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 302 | $34,730 | $25,130 | 72.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 191 | $30,338 | $22,214 | 73.2% |
| 98928 | Osteopathic manipulative treatment, 7-8 body regions | Office | 2022 | 54 | 233 | $19,805 | $15,217 | 76.8% |
| 98929 | Osteopathic manipulative treatment, 9-10 body regions | Office | 2022 | 45 | 188 | $20,130 | $14,426 | 71.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $12,070 | $7,522 | 62.3% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 14 | 46 | $5,750 | $4,187 | 72.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 11 | 22 | $5,185 | $3,686 | 71.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 36 | $2,700 | $1,918 | 71.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 11 | 22 | $2,775 | $1,916 | 69.1% |
| 76881 | Complete ultrasound scan of joint | Office | 2022 | 22 | 26 | $3,133 | $1,438 | 45.9% |
About Dr. Michael Florek, DO
Dr. Michael Florek, DO is a Neuromusculoskeletal Medicine & OMM healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2017. The National Provider Identifier (NPI) number assigned to this provider is 1831626373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Florek, DO has received a total of $719.28 in payments from pharmaceutical and medical device companies, with $139.72 received in 2024. These payments were reported across 13 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($719.28).
As a Medicare-enrolled provider, Florek has provided services to 1,225 Medicare beneficiaries, totaling 3,987 services with total Medicare billing of $337,752. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Neuromusculoskeletal Medicine & OMM
- Location New York, NY
- Active Since 05/15/2017
- Last Updated 07/08/2024
- Taxonomy Code 204D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831626373
Products in Payments
- BOTOX (Biological) $187.04
- General - Pain Management (Device) $166.36
- UBRELVY (Drug) $122.43
- FASENRA (Drug) $117.72
- BREZTRI (Drug) $109.28
- REXULTI (Drug) $16.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neuromusculoskeletal Medicine & OMM Doctors in New York
Francis Yoo, D.o, D.O
Neuromusculoskeletal Medicine & OMM — Payments: $571.74
Dr. John Juhl, D.o, D.O
Neuromusculoskeletal Medicine & OMM — Payments: $325.68
Dr. Shanna Patterson, M.d, M.D
Neuromusculoskeletal Medicine & OMM — Payments: $188.59
Dr. Kevin Weiss, Do, DO
Neuromusculoskeletal Medicine & OMM — Payments: $166.03
Nadine Keegan, M.d, M.D
Neuromusculoskeletal Medicine & OMM — Payments: $39.61
George Unis, M.d, M.D
Neuromusculoskeletal Medicine & OMM — Payments: $17.60